News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • FingerMotion signed a binding LOI to buy ~20.2 acres in Hanna, Alberta for a second campus under its 99 MW Alberta program.
  • The site offers 3 MW grid power plus natural gas interconnection for behind-the-meter generation.
  • Planned powered campus capacity is 9.9 MW targeting AI and HPC clients.
  • FingerMotion will secure permits, power, and client contracts before committing to construction.
  • Development and construction will be handled by BlueFlare Group Holdings.
  • The move expands FingerMotion's AI/HPC footprint and supports demand for regional data center capacity in Alberta.

Latest Articles

Kaltura Delivers Record-Scale Live Streaming for the 2026 FIFA World Cup, Previews Agentic Avatar Experiences for Live Sports

Kaltura Delivers Record-Scale Live Streaming for the 2026 FIFA World Cup, Previews Agentic Avatar Experiences for Live Sports

Kaltura successfully delivered live TV streaming for the 2026 FIFA World Cup, handling a record demand with 1.3 billion playback sessions and 7 million concurrent viewers across six production environments globally. The company revamped its platform to a microservices architecture for better scalability and deployed AI agents to optimize live event…

Enphase Energy Publishes White Paper on Kestrel ASIC, Its Fifth-Generation Silicon Platform for Intelligent Power Conversion

Enphase Energy Publishes White Paper on Kestrel ASIC, Its Fifth-Generation Silicon Platform for Intelligent Power Conversion

Enphase Energy has published a white paper detailing its fifth-generation Kestrel application-specific integrated circuit (ASIC) designed to enhance intelligent power conversion in multiple product lines including microinverters, IQ Battery systems, EV chargers, and solid-state transformers. The Kestrel ASIC integrates advanced power control, secur…

Lightbridge Corporation and Quadrant Nuclear Industries Announce Memorandum of Understanding to Advance Domestic HALEU Fuel Supply

Lightbridge Corporation and Quadrant Nuclear Industries Announce Memorandum of Understanding to Advance Domestic HALEU Fuel Supply

Lightbridge Corporation (Nasdaq: LTBR) and Quadrant Nuclear Industries Inc. (QNI) have signed a non-binding memorandum of understanding to collaborate on establishing a domestic supply chain for high-assay low-enriched uranium (HALEU) fuel, essential for advanced nuclear reactors. This partnership aims to support Lightbridge's commercialization of …

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Pacira BioSciences has transitioned its investigational gene therapy, PCRX-201, for knee osteoarthritis to a scalable U.S.-based commercial manufacturing process. This enabled enrollment of the first patient in Part B of the Phase 2 ASCEND study, with topline Part A data expected by end of 2026. The transition supports the company's growth strategy…

Genius Group Offers Share Loyalty Bonus Program Delivering up to 59% Return on Investment in six months, Closing July 31, 2026.

Genius Group Offers Share Loyalty Bonus Program Delivering up to 59% Return on Investment in six months, Closing July 31, 2026.

Genius Group Limited (NYSE American: GNS) announced the second round of its Share Loyalty Bonus Program, paying shareholders a $0.10 per share cash bonus after a six-month holding period. With the company's current share price at $0.17, this bonus represents a 59% return on investment and rewards long-term shareholders who hold their shares in book…

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

Freenome's SimpleScreen CRC blood-based colorectal cancer screening test received FDA approval for adults 45 and older at average risk. Abbott will commercialize the test in the U.S., leveraging its existing colorectal cancer screening infrastructure. The approval supports broader access, including Medicare coverage and American Cancer Society endo…

Waterco Modernizes B2B Ordering with BigCommerce, Improving Ordering and Buying Efficiency Across 45,000 Products

Waterco Modernizes B2B Ordering with BigCommerce, Improving Ordering and Buying Efficiency Across 45,000 Products

Commerce (Nasdaq: CMRC) announced that Waterco, a global swimming pool products manufacturer and distributor, has launched a new B2B buying experience using BigCommerce platform. By shifting from manual phone and email orders to a self-service digital platform handling over 45,000 products, Waterco aims to improve operational efficiency, support sc…

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting

Humacyte, Inc. announced FDA acceptance of its Investigational New Drug application to begin a Phase 2a clinical study evaluating its Coronary Tissue Engineered Vessel (CTEV) as an off-the-shelf alternative for coronary artery bypass grafting (CABG). This marks a significant advancement in coronary artery disease treatment, offering potential impro…

Amaze Announces Full Compliance with NYSE American Continued Listing Standards and Resumption of Trading

Amaze Announces Full Compliance with NYSE American Continued Listing Standards and Resumption of Trading

Amaze Holdings, Inc., a creator-powered commerce platform, announced that it has regained compliance with all NYSE American continued listing standards following its 1-for-8 reverse stock split. Consequently, its common stock will resume trading on the NYSE American under ticker AMZE on a split-adjusted basis. The company is currently evaluating st…

Swarmer and Brightline Partner on AI Data Collection and Drone Interoperability for U.S. Department of War

Swarmer and Brightline Partner on AI Data Collection and Drone Interoperability for U.S. Department of War

Swarmer, Inc., a Nasdaq-listed drone autonomy software company, has signed a memorandum of understanding with Brightline Interactive to jointly develop integrated AI and drone interoperability solutions for the U.S. Department of War. The partnership aims to combine Swarmer's combat-tested autonomous swarm coordination software with Brightline's Sp…

Carpenter Technology Announces the Passing of Brian Malloy

Carpenter Technology Announces the Passing of Brian Malloy

Carpenter Technology Corporation announced the sudden passing of its President and CEO Brian Malloy. The company’s Executive Chairman, Tony Thene, has been appointed CEO effective immediately. Malloy was recognized for his significant contributions over the past decade. The company reaffirmed its leadership continuity and commitment to operational …

Rezolve Ai Delivers Breakout First-Half Performance: Preliminary H1 2026 Revenue Expected to Reach Approximately $127 Million, Nearly 20x H1 2025

Rezolve Ai Delivers Breakout First-Half Performance: Preliminary H1 2026 Revenue Expected to Reach Approximately $127 Million, Nearly 20x H1 2025

Rezolve Ai disclosed preliminary H1 2026 revenue of approximately $127 million, a nearly 20-fold increase from $6.32 million in H1 2025, surpassing full-year 2025 revenue by more than 2.7 times. The company reaffirmed its 2026 revenue guidance of $360 million, supported by strong momentum in enterprise deployments, major partnerships including Tata…

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Fortress Biotech's subsidiary Urica Therapeutics announces that Crystalys Therapeutics secured $130 million in an oversubscribed Series B financing to support global clinical development and commercialization of dotinurad, a once-daily oral URAT1 inhibitor aimed at treating gout. Crystalys is conducting multiple Phase 2 and Phase 3 studies, includi…

EagleNXT Joint Venture “ThirdEye USA” Selected to Participate in EXTiC 26-2 Counter-UAS Experimentation Event

EagleNXT Joint Venture “ThirdEye USA” Selected to Participate in EXTiC 26-2 Counter-UAS Experimentation Event

AgEagle Aerial Systems Inc. (EagleNXT) announced that its joint venture ThirdEye USA has been selected to participate in the U.S. Central Command's EXTiC 26-2 experimentation event. The event focuses on testing advanced counter-UAS technologies in simulated combat scenarios, potentially accelerating their adoption by the U.S. military. ThirdEye USA…

Franklin Electric Declares Quarterly Dividend of $0.28 Per Share

Franklin Electric Declares Quarterly Dividend of $0.28 Per Share

Franklin Electric Co., Inc. announced a quarterly dividend of $0.28 per share payable on August 20, 2026, to shareholders of record on August 6, 2026. The company, a global leader in water and energy movement systems and components, emphasized its strong market position and recognized leadership in corporate responsibility. The announcement include…

Siebert Financial partners with Kakao Pay Securities to Launch Trading of 24-hr Tokenized Korean Stocks

Siebert Financial partners with Kakao Pay Securities to Launch Trading of 24-hr Tokenized Korean Stocks

Siebert Financial Corp. has partnered with Kakao Pay Securities to launch an innovative model called the "K-Stock Global Gateway," designed to allow American investors to trade South Korean equities beyond traditional market hours via tokenization technology. This partnership aims to overcome time zone barriers and facilitate round-the-clock tradin…

Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors

Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors

Inspire Medical Systems, a US-based medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, announced the appointment of Michael H. Carrel to its Board of Directors. Carrel brings significant leadership experience from his roles at AtriCure and Axonics, with a strong background in advancing innovative me…